Profil
Kristin Stephens is currently the Chief Development Officer at Syros Pharmaceuticals, Inc. She previously worked as the Vice President-Global Clinical Operations at Millennium Pharmaceuticals, Inc. and as a Vice President at Takeda Pharmaceuticals U.S.A., Inc. She completed her undergraduate degree at Hobart & William Smith Colleges.
Aktive Positionen von Kristin Stephens
| Unternehmen | Position | Beginn |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2018 |
Ehemalige bekannte Positionen von Kristin Stephens
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Ausbildung von Kristin Stephens
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hobart & William Smith Colleges
Hobart & William Smith Colleges Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
















